IP Library › Granted Patent US 7,963,959
Granted Patent B2
US 7,963,959 · App. 12/617,565 · Granted Jun 21, 2011

Automated cryogenic skin treatment

Assignee: Vandolay, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,963,959
App. No.
12/617,565
Granted
Jun 21, 2011
Kind
B2
Abstract

An apparatus and methods for treating lesions on skin are presented. The apparatus collects information about a lesion and can automatically determine a course of treatment for the lesion. The device can include a controller that positions the nozzle proximate to a surface region of the lesion and automatically dispenses a pulse of the cryogenic fluid from the nozzle. The controller then positions the nozzle proximate to another surface region of the lesion and automatically dispenses a pulse of the cryogenic fluid from the nozzle.

Claims (23)

1. An apparatus for treating a lesion of an area of skin using a cryogenic fluid, comprising:

a dispensing nozzle configured to dispense the cryogenic fluid;

a valve that regulates flow of the cryogenic fluid to the nozzle;

a positioner disposed to move the nozzle;

an electronic image acquisition system that examines the skin to acquire information about the lesion;

a controller programmed to use the information to determine a sequential, multi-pulsed course of treatment for the lesion, in which the device automatically dispenses a first pulse of the cryogenic fluid at a first surface region of the lesion, automatically redirects the nozzle, and then dispenses a second pulse of the cryogenic fluid at a second surface region of the lesion;

wherein the first surface region has a first center and wherein the second surface region has a second center; and

wherein the first and second centers of the surface regions are separate and are separated by no more than 5 mm, and the first and second pulses are sequential and separated by no more than 30 seconds, and wherein the first and second pulses of the cryogenic fluid are effective to cause a lysis of tissue of the first and second surface regions, respectively.

2. The apparatus of claim 1 , wherein the electronic image acquisition system is configured to identify a type of lesion as at least one of an age spot, a wart, and a melasma, and wherein the information comprises the type of lesion.

3. The apparatus of claim 1 , wherein the centers of the regions are separated by no more than 2 mm.

4. The apparatus of claim 1 , wherein the centers of the regions are separated by no more than 1 mm.

5. The apparatus of claim 1 , wherein the first and second pulses are separated by no more than 20 seconds.

6. The apparatus of claim 1 , wherein the first and second pulses are separated by no more than 10 seconds.

7. The apparatus of claim 1 , further comprising a spacer that passively maintains a nearly constant distance between the nozzle and the lesion.

8. The apparatus of claim 1 , further comprising first and second optical beams that operate in conjunction with the electronic image acquisition system to provide the controller with z-axis information relative to the first and second surfaces of the lesion.

9. The apparatus of claim 1 , wherein the positioner comprises an arm that provides for three-dimensional movement of the nozzle.

10. The apparatus of claim 1 wherein the controller analyzes a change in at least one of a coloration and a temperature of at least one of the first and second surface regions of the lesion.

11. The apparatus of claim 1 , further comprising a mechanism that causes physical rotation of the lesion.

12. The apparatus of claim 1 , further comprising a second nozzle configured to dispense the cryogenic fluid at a third surface region of the lesion.

13. The apparatus of claim 1 further comprising a sensor configured to monitor a movement of the lesion, and provide feedback to a controller.

14. The apparatus of claim 1 wherein the cryogenic fluid is selected from the list consisting of liquid carbon dioxide, difluoroethane, dichloro difluoro methane, and tetrafluoroethane.

15. The apparatus of claim 1 , where the first and second surface regions of the lesion overlap.

16. The apparatus of claim 1 , wherein the lysis of tissue of the first and second surface regions is a result of the first and second pulses lowering a temperature of the first and second surface regions, respectively.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2018
From: LILY INNOVATION ADVISORS LTD.
To: BIONOVATE TECHNOLOGIES CORP.
Reel/Frame 044785/0641 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2014
From: VANDOLAY, INC.
To: LILY INNOVATION ADVISORS LTD
Reel/Frame 033957/0760 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2009
From: DA SILVA, LUIZ; COHEN, DONALD; LIEBERMAN, MARC
To: VANDOLAY, INC.
Reel/Frame 023512/0430 →
Continuity (3)
Continuation 12575370 · Oct 7, 2009
Provisional Application 61103285 · Oct 7, 2008
Related Publication 20100087807A1 · Apr 8, 2010